Shinya Ikeda

Research Fellow, Kyoto University

1 active project

Bleeding risk on anticoagulant or antithrombotic therapy

Bleeding is a major adverse event for patients with anticoagulant or antithrombotic therapy. Identifying genetic, environmental, and comorbidity risks for bleeding with anticoagulant or antithrombotic therapy is required.

Scientific Questions Being Studied

Bleeding is a major adverse event for patients with anticoagulant or antithrombotic therapy. Identifying genetic, environmental, and comorbidity risks for bleeding with anticoagulant or antithrombotic therapy is required.

Project Purpose(s)

  • Drug Development
  • Ancestry

Scientific Approaches

We plan to use the All of Us Database to identify a cohort of patients with anticoagulant or antithrombotic therapy. We will seek the disease that increase the bleeding and will look at genetic risks without these diseases.

Anticipated Findings

We anticipate identifying genetic risks and disease risks for bleeding with anticoagulant or antithrombotic therapy. We can change the duration of therapy with a more accurate prediction model.

Demographic Categories of Interest

  • Geography

Data Set Used

Controlled Tier

Research Team

Owner:

1 - 1 of 1
<
>
Request a Review of this Research Project

You can request that the All of Us Resource Access Board (RAB) review a research purpose description if you have concerns that this research project may stigmatize All of Us participants or violate the Data User Code of Conduct in some other way. To request a review, you must fill in a form, which you can access by selecting ‘request a review’ below.